This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ghosh R, Tabrizi SJ. (2018). Clinical Features of Huntington’s Disease. Adv Exp Med Biol., 1049:1-28. Doi: 10.1007/978-3-319-71779-1_1. PMID: 29427096.GhoshRTabriziSJ. (2018). Clinical Features of Huntington’s Disease. Adv Exp Med Biol., 1049: 1-28. Doi: 10.1007/978-3-319-71779-1_1. PMID: 29427096.Open DOISearch in Google Scholar
Harper PS. (1991). Huntington’s Disease. Major Problems in Neurology 22, London, WB Saunders Company Ltd. p.3.HarperPS. (1991). Huntington’s Disease. Major Problems in Neurology 22, London, WB Saunders Company Ltd.p.3.Search in Google Scholar
Hayden MR. (1981). Huntington’s Chorea. Berlin, Heidelberg, Springer-Verlag. Chapter 5, p.59.HaydenMR. (1981). Huntington’s Chorea. Berlin, Heidelberg, Springer-Verlag. Chapter 5, p.59.Search in Google Scholar
Medina A, Mahjoub Y, Shaver L, Pringsheim T. (2022). Prevalence and Incidence of Huntington’s Disease: An Updated Systematic Review and Meta-Analysis. Mov Disord. Dec;37(12):2327-2335. Doi: 10.1002/mds.29228. Epub 2022 Sep 26. PMID: 36161673.MedinaAMahjoubYShaverLPringsheimT. (2022). Prevalence and Incidence of Huntington’s Disease: An Updated Systematic Review and Meta-Analysis. Mov Disord.Dec;37(12):2327-2335. Doi: 10.1002/mds.29228. Epub 2022 Sep 26. PMID: 36161673.Open DOISearch in Google Scholar
Piña-Aguilar RE, Simpson SA, Alshatti A, Clarke A, Craufurd D, Dorkins H, Doye K, Lahiri N, Lashwood A, Lynch C, Miller C, Morton S, O’Driscoll M, Quarrell OW, Rae D, Strong M, Tomlinson C, Turnpenny P, Miedzybrodzka Z; UK HD Predictive Testing Consortium. (2019). 27 years of prenatal diagnosis for Huntington disease in the United Kingdom. Genet Med. Jul;21(7):1639-1643. Doi: 10.1038/s41436-018-0367-z. Epub 2018 Dec 14. PMID: 30546084.Piña-AguilarRESimpsonSAAlshattiAClarkeACraufurdDDorkinsHDoyeKLahiriNLashwoodALynchCMillerCMortonSO’DriscollMQuarrellOWRaeDStrongMTomlinsonCTurnpennyPMiedzybrodzkaZUK HD Predictive Testing Consortium. (2019). 27 years of prenatal diagnosis for Huntington disease in the United Kingdom. Genet Med.Jul;21(7):1639-1643. Doi: 10.1038/s41436-018-0367-z. Epub 2018 Dec 14. PMID: 30546084.Open DOISearch in Google Scholar
Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, Smeeth L. (2016). The Prevalence of Huntington’s Disease. Neuroepidemiology. 46(2):144-53. doi: 10.1159/000443738. Epub 2016 Jan 30. PMID: 26824438.RawlinsMDWexlerNSWexlerARTabriziSJDouglasIEvansSJSmeethL. (2016). The Prevalence of Huntington’s Disease. Neuroepidemiology.46(2): 144-53. doi: 10.1159/000443738. Epub 2016 Jan 30. PMID:26824438.Open DOISearch in Google Scholar
Quaid KA. (2017). Genetic testing for Huntington disease. Handb Clin Neurol. 144:113-126. doi: 10.1016/B978-0-12-801893-4.00010-9. PMID: 28947110.QuaidKA. (2017). Genetic testing for Huntington disease. Handb Clin Neurol.144: 113-126. doi: 10.1016/B978-0-12-801893-4.00010-9. PMID:28947110.Open DOISearch in Google Scholar
Samperi SV, Kwong P, McGill T. (2021). Huntington’s disease: A Nursing Perspective. AJON. 31(2), 18-26. Doi:10.21307/ajon-2021 -007SamperiSVKwongPMcGillT. (2021). Huntington’s disease: A Nursing Perspective. AJON.31(2), 18-26. doi: 10.21307/ajon-2021 -007Open DOISearch in Google Scholar
Sathe S, Ware J, Levey J, Neacy E, Blumenstein R, Noble S, Mühlbäck A, Rosser A, Landwehrmeyer GB, Sampaio C. (2021). Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington’s Disease. Front Neurol. Aug 18;12:667420. doi: 10.3389/fneur.2021.667420. PMID: 34484094; PMCID: PMC8416308.SatheSWareJLeveyJNeacyEBlumensteinRNobleSMühlbäckARosserALandwehrmeyerGBSampaioC. (2021). Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington’s Disease. Front Neurol.Aug18;12: 667420. doi: 10.3389/fneur.2021.667420. PMID:34484094; PMCID: PMC8416308.Open DOISearch in Google Scholar
Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC, Flower MD, Scahill RI, Wild EJ, MuñozSanjuan I, Sampaio C, Rosser AE, Leavitt BR. (2022). Potential disease-modifying therapies for Huntington’s disease: lessons learned and future opportunities. Lancet Neurol. Jul;21(7):645-658. doi: 10.1016/S1474-4422(22)00121-1. PMID: 35716694; PMCID: PMC7613206.TabriziSJEstevez-FragaCvan Roon-MomWMCFlowerMDScahillRIWildEJMuñozSanjuanISampaioCRosserAELeavittBR. (2022). Potential disease-modifying therapies for Huntington’s disease: lessons learned and future opportunities. Lancet Neurol.Jul;21(7):645-658. doi: 10.1016/S1474-4422(22)00121-1. PMID:35716694; PMCID: PMC7613206.Open DOISearch in Google Scholar
The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. Mar 26;72(6):971-83. doi: 10.1016/0092-8674(93)90585-e. PMID: 8458085The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell.Mar 26;72(6): 971-83. doi: 10.1016/0092-8674(93)90585-e. PMID:8458085Open DOISearch in Google Scholar